Protein phosphatase1 regulates normal automaticity of heart pacemaker node cells

蛋白磷酸酶1调节心脏起搏器节点细胞的正常自律性

基本信息

  • 批准号:
    8931599
  • 负责人:
  • 金额:
    $ 38.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

In freshly isolated rabbit SANC, Protein Phosphatase Inhibition (PPI) by the PP1/2A inhibitor, Calyculin A, (100-500 nM) reduced PP activity by 90%, and increased basal PLB phosphorylation at Thr17 and Ser16 by about 2.5-fold. PPI increased: the rate of spontaneous Ca2+ release of the LCR ensemble (measured via confocal fluo-4 imaging) by nearly four-fold in saponin-permeabilized SANC; the L-type Ca2+ current (ICaL) amplitude by 30% in voltage-clamped, single SANC; and the LCR size in spontaneously firing single, intact SANC. PPI also decreased the LCR period, and this reduction predicted a concurrent 25% reduction in the spontaneous AP cycle length. We found that PP are important regulators of PDE functioning: addition of PP inhibitors to the reaction buffer increased total PDE activity approximately 50 % in both SANC and VM lysates. We found that PP1 is present in SANC via Western Blot technique. A numerical model simulation of the effect of PPI on SANC firing rate, incorporating experimental observed changes in ICaL and PLB phosphorylation effects on SR Ca2+ pumping, closely predicted the experimental results. We measured expression of different types of PPs and PP1 inhibitors mRNAs in SANC, LV and RA cells. Conclusion: Basal PP activity modulates spontaneous SANC AP firing rate, in part at least, by modulating ICaL, PLB phosphorylation, and SR-generated LCRs. We identified transcripts coding PP1, PP2A, PP2B and PP1 inhibitors in VM, RA and SANC. We found that the level of all of these transcripts except PP2B was significantly lower in SANC compared to VM. In order to see partitioning of different PPs in the total picture of cell ability to dephosphorylate proteins, we have modified Promega ProFluor Ser/Thr PPase assay, and now we are able to measure PP activity in cell lysates in the same conditions for PP1, PP2A, PP2B and PP2C. We found that PP2A is a dominant PP in SANC. In order to differentiate between PP1 and PP2A, we studied dose-dependent effects of Calyculin A and Okadaic acid at low nanomolar concentrations and found that PP2A is more sensitive to these inhibitors than PP1. We found that PP1 is present in SANC, but its relative activity is low. We tried to discern the PP1 partitioning by using I-1, the most specific PP1 inhibitor. Unfortunately, this approach did not help, mainly due to the high level of PP2A activity in cells, contamination in the activated I-1 and low level of PP1 (relatively to the total variability). Knowing that in cells PP are often located in different microenvironments (for example they can be bound to scaffolding proteins), now we are developing a new approach to investigate role of PPs in cell functioning. Currently we are developing methods of immunoprecipitation of the most important complexes in SANC and VM in order to detect via co-immunoprecipitation (with further Western blot and mass spectrometry analysis) which PPs are bound to them and are involved in their functioning. Initially, we took SERCA and mAKAP as our targets. This method is especially important because even low abundant phosphatase can have an important and specific role in cell regulation. Currently we continue our work to develop and improve co-immunoprecipitation techniques. The most recent experiments demonstrated that activity of PPs depends tremendously on cations present in phosphatase reaction. We have developed conditions in which PP2A activity is not so high but at the same time PP1 and PP2B activities appear much higher than previously. Using Calyculin A and Okadaic acid at low nanomolar concentrations under the new conditions helped us demonstrate a much clearer presence of PP1 and PP2B activities in SANC. These data also prove the importance of intracellular microenvironment cation balance in the activities of PPs.
在新分离的兔SANC中,PP1/2A抑制剂Calyculin A (100-500 nM)抑制蛋白磷酸酶(PPI)可使PP活性降低90%,并使PLB Thr17和Ser16的基础磷酸化增加约2.5倍。PPI增加:在皂素渗透的SANC中,LCR集合的自发Ca2+释放率(通过共聚焦荧光成像测量)增加了近四倍;l型Ca2+电流(ICaL)幅值在电压箝位的单一SANC中提高30%;以及自燃单一完整SANC的LCR大小。PPI也缩短了LCR周期,这种减少预示着自发性AP周期长度同时减少了25%。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edward Lakatta其他文献

Edward Lakatta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edward Lakatta', 18)}}的其他基金

A PUFA Dietary Intervention for Heart Rate
PUFA 饮食干预心率
  • 批准号:
    8335786
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
Decreased pacemaker activity in aged sinoatrial node
老年窦房结起搏器活动减少
  • 批准号:
    8335801
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
Soluble Receptor for Advanced Glycation End Products for Therapeutic Application
用于治疗应用的高级糖基化终产物的可溶性受体
  • 批准号:
    8552494
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
Therapeutic Potential of EPO and its Derivatives for Reducing Blood Pressure
EPO 及其衍生物降低血压的治疗潜力
  • 批准号:
    9147229
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
The VALIDATE study
验证研究
  • 批准号:
    8736504
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
The REVEAL study
REVEAL 研究
  • 批准号:
    8552344
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
Effects Of Age And Conditioning Status On Rest And Exercise Cardiac Performance
年龄和体能状态对休息和运动心脏功能的影响
  • 批准号:
    8931601
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
Matching ATP supply and demand in cardiac pacemaker cells
匹配心脏起搏细胞中的 ATP 供应和需求
  • 批准号:
    8931611
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
PDE3, PDE4 and PKC regulate local Ca2+ releases and cardiac pacemaker firing
PDE3、PDE4 和 PKC 调节局部 Ca2 释放和心脏起搏器放电
  • 批准号:
    8736511
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling
动脉蛋白质组和主动脉平滑肌信号与年龄相关的变化
  • 批准号:
    8931487
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:

相似海外基金

The bacterial class IIIb adenylate cyclase CyaC-Sm of Sinorhizobium meliloti: Redox sensing by a heme B binding membrane anchor
苜蓿中华根瘤菌的细菌 IIIb 类腺苷酸环化酶 CyaC-Sm:通过血红素 B 结合膜锚进行氧化还原传感
  • 批准号:
    361006731
  • 财政年份:
    2017
  • 资助金额:
    $ 38.01万
  • 项目类别:
    Research Grants
A GTP-binding peptide regulates beta-adrenergic response of adenylate cyclase
GTP 结合肽调节腺苷酸环化酶的 β 肾上腺素能反应
  • 批准号:
    05670111
  • 财政年份:
    1993
  • 资助金额:
    $ 38.01万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Regulation of Adenylate Cyclase Activity by a GTP-Binding Peptida in Rat Liver.
GTP 结合肽对大鼠肝脏中腺苷酸环化酶活性的调节。
  • 批准号:
    63570105
  • 财政年份:
    1988
  • 资助金额:
    $ 38.01万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    4694493
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3919997
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3966536
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3878895
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3779504
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3942781
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3843261
  • 财政年份:
  • 资助金额:
    $ 38.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了